About Us
Regenerative Medicine of Europe (RME) owns the rights to drug therapies that are in development to treat Parkinson's Disease, ALS, Stroke Recovery, Alzheimer’s Disease, MSA, Vascular Dementia, CTE, TBI, Diabetic Foot Ulcers, Venous Leg Ulcers, Coronary Artery Disease, Peripheral Artery Disease (PAD), and MS.
RME owns a portfolio of biological drugs that will keep its drug pipeline full for many decades.
LEADERSHIP
At RME, we have built a great team and have developed relationships that will make us successful in reaching
our goals.
FUTURE
INNOVATIVE
THERAPIES
We believe that Regenerative Medicine is the future of healthcare. Many of the problems of our aging bodies are from the lack of blood flow to organs which can cause a number of negative effects on our body and our health.